Dipeptide derivatives having a nterminal 2-thioacyl group as vasopeptidase inhibitors

Details for Australian Patent Application No. 2002314067 (hide)

Owner Novartis AG

Inventors Fink, Cynthia Anne

Agent Davies Collison Cave

Pub. Number AU-B-2002314067

PCT Number PCT/EP02/05293

PCT Pub. Number WO2002/092622

Priority 60/291,088 15.05.01 US; 60/339,575 11.12.01 US

Filing date 14 May 2002

Wipo publication date 25 November 2002

Acceptance publication date 16 March 2006

International Classifications

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 60/291,088 15.05.01 US; 60/339,575 11.12.01 US

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002314067

16 March 2006 Application Accepted

  Published as AU-B-2002314067

20 July 2006 Standard Patent Sealed

8 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002314068-DEVICE AND METHOD FOR DETERMINING A PHYSICAL ADDRESS FROM A VIRTUAL ADDRESS, USING A HIERARCHICAL MAPPING RULE COMPRISING COMPRESSED NODES

2002314066-MICROPAYMENT SYSTEM